Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

Kudo et al.

  • Annals of Oncology
  • September 2019

Clonal replacement of tumor-specific T cells following PD-1 blockade

Yost et al.

  • Nature Medicine
  • August 2019

The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients

Khunger et al.

  • OncoImmunology
  • August 2019

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.

Ross et al.

  • Prostate Cancer and Prostatic Diseases
  • August 2019

Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy

Shah et al.

  • Blood Advances
  • August 2019

The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity

Palakurthi et al.

  • Cancer Immunology Research
  • July 2019

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor- induced encephalitis

Johnson et al.

  • Nature Medicine
  • July 2019

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Wang et al.

  • Nature Immunology
  • July 2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Kuehm et al.

  • Cancer Immunology and Immunotherapy
  • May 2019